Dartmouth's Therabot, tested in a 210-person randomized trial published March 2025 in NEJM AI, showed a 51% symptom reduction for depression and 31% for anxiety, offering the first clinical-trial evidence that a purpose-built AI chatbot can meaningfully treat mental illness.
After Samsung, Apple, PranaQ, and Happy Health all won FDA clearances for AI-powered sleep apnea detection on wearables in 2025, the FDA issued new January 2026 guidance clarifying which wellness claims wearables can make without full medical-device review.
Medtronic unveiled Touch Surgery Aide, a real-time AI computing platform for robotic operating rooms, featuring an FDA-cleared instrument tracking feature debuted at the Society of Robotic Surgery's 2026 meeting.
Researchers at Hong Kong University of Science and Technology built PRET, an AI pathology system that recognizes 18 cancer types from a handful of slides without needing retraining for each new hospital.
A multisite validation study found Duke Health's Sepsis Watch AI model, credited with a 27% drop in sepsis deaths at Duke, performed just as strongly after being deployed at a different community hospital system.
DeepMind's new 'prospective credit assignment' method trains models to anticipate the downstream value of their own reasoning steps, aiming at faster self-correction in agentic AI.
Utah's AI chatbot Doctronic can now refill prescriptions without a doctor visit, sparking a national debate over accountability and patient safety.
From many particular things we form a single idea that captures what they share and ignores the rest.
A search for the lowest point can end in a valley that is low but not lowest.
To find the bottom of a valley in fog, take small steps downhill.